# Gamma Induction for Alzheimer's Disease

> **NCT03880240** · PHASE1,PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 17 (actual)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

- **DEVICE:** Transcranial Alternating Current Stimulation (tACS)
- **OTHER:** Sham Transcranial Alternating Current Stimulation

## Key facts

- **NCT ID:** NCT03880240
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-05
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2026-03-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03880240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03880240, "Gamma Induction for Alzheimer's Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03880240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*